Imai T, Carrillo V M, Yokoi H, Noguchi T, Kawarada Y, Mizumoto R
First Department of Surgery, Mie University School of Medicine, Japan.
Gastroenterol Jpn. 1990 Feb;25(1):54-60. doi: 10.1007/BF02785330.
The present study was undertaken to elucidate clinicopathological findings and operative results of HCC with HB-associated cirrhosis, compared with those in HCC patients with alcoholic and post-transfusion cirrhosis. The number of the HBV group was 26 cases, consisting of 17 in sAg(+), 4 in eAg(+) and 5 in eAb(+) subgroups. The number of the post-transfusion group was 7 and that of alcoholic group was 12. A high incidence of hypersplenism and esophageal varix in the eAg(+) subgroup was found. ICG R15 was the highest, KICG and ICG Rmax were the lowest in the eAg(+) subgroup. The mean diameter of tumors was the largest, 6.6 +/- 3.9 cm, in the sAg(+) subgroup and was the smallest, 2.2 +/- 1.7 cm, in the eAg(+) subgroup. The incidence of postoperative jaundice, hyperammoninemia and live dysfunction were the highest in the sAg(+) and eAg(+) subgroup. One and three-year survival rate were 76.9% and 48.1% in the sAg(+) subgroup, 60.0% and 30.0% in the eAb(+) subgroup, and the one-year survival rate in the eAg(+) subgroup was 50.0%. The three-year survival rate could not be calculated because 3 years had not passed since the operation. The prognosis was the poorest in the HBV group among all groups. This study suggests that in HBV-associated cirrhosis, hepatectomy might induce "acute on chronic" changes (acute hepatitis and fulminant hepatitis). Therefore we should select operative procedures by considering surgical risk and the etiology of liver cirrhosis in hepatectomy.
本研究旨在阐明与酒精性肝硬化和输血后肝硬化的肝癌患者相比,乙肝相关性肝硬化肝癌患者的临床病理特征和手术结果。乙肝组有26例患者,包括17例表面抗原(sAg)阳性、4例e抗原(eAg)阳性和5例e抗体(eAb)阳性亚组。输血后组有7例,酒精性组有12例。发现eAg阳性亚组脾功能亢进和食管静脉曲张的发生率较高。eAg阳性亚组的吲哚氰绿(ICG)滞留率(R15)最高,KICG和ICG最大清除率(Rmax)最低。肿瘤平均直径在sAg阳性亚组最大,为6.6±3.9 cm,在eAg阳性亚组最小,为2.2±1.7 cm。术后黄疸、高氨血症和肝功能障碍的发生率在sAg阳性和eAg阳性亚组最高。sAg阳性亚组的1年和3年生存率分别为76.9%和48.1%,eAb阳性亚组为60.0%和30.0%,eAg阳性亚组的1年生存率为50.0%。由于手术后未到3年,eAg阳性亚组的3年生存率无法计算。所有组中乙肝组的预后最差。本研究表明,在乙肝相关性肝硬化中,肝切除术可能诱发“慢性基础上的急性”变化(急性肝炎和暴发性肝炎)。因此,在肝切除术中,我们应通过考虑手术风险和肝硬化病因来选择手术方式。